COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,740 Articles (22,502 medRxiv, 8,238 bioRxiv)

Most recent first Previous |  Page 1422: Articles 14211-14220  | Next

Transmission of SARS-CoV-2 associated with aircraft travel: a systematic review (Version 1)
Rosca, E. C., Heneghan, C., Spencer, E. A., Brassey, J., Pluddemann, A., Onakpoya, I., Evans, D. H., Conly, J. M., Jefferson, T.
10.1101/2021.06.03.21258274 — Posted: 2021-06-05
Clinical performance of two EUA-approved anti-COVID-19 IgG/IgM rapid lateral flow immunoassays using whole blood finger-sticks
Tagwerker, C., Baig, I., Brunson, E., Mundo, K., Dutra-Smith, D., Carias-Marines, M. J., de Zoysa, R. S., Smith, D. J.
10.1101/2021.06.04.21258189 — Posted: 2021-06-05
Direct comparison of venipuncture serum draws versus whole blood finger-stick specimens by anti-COVID-19 IgG/IgM rapid lateral flow immunoassay and ELISA.
Baig, I., Tagwerker, C., Brunson, E. J., Mundo, K., Dutra-Smith, D., Carias, M. J., de Zoysa, R. S., Smith, D. J.
10.1101/2021.06.04.21258182 — Posted: 2021-06-05
Multisystemic cellular tropism of SARS-CoV-2 in autopsies of COVID-19 patients
Wong, D. W. L., Klinkhammer, B. M., Djudjaj, S., Villwock, S., Timm, M. C., Buhl, E. M., Wucherpfennig, S., Cacchi, C., Braunschweig, T., Knüchel-Clarke, R., Jonigk, D., Werlein, C., Bülow, R. D., Dahl, E., von Stillfried, S., Boor, P.
10.1101/2021.06.03.21258241 — Posted: 2021-06-05
Vaccine nationalism and the dynamics and control of SARS-CoV-2
Wagner, C. E., Saad-Roy, C. M., Morris, S. E., Baker, R. E., Mina, M. J., Farrar, J., Holmes, E. C., Pybus, O. G., Graham, A. L., Emanuel, E. J., Levin, S. A., Metcalf, C. J. E., Grenfell, B. T.
10.1101/2021.06.02.21258229 — Posted: 2021-06-05
Group Testing Large Populations for SARS-CoV-2
Zabeti, H., Dexter, N., Lau, I., Unruh, L., Adcock, B., Chindelevitch, L.
10.1101/2021.06.03.21258258 — Posted: 2021-06-05
Effectiveness of mRNA COVID-19 Vaccines among Employees in an American Healthcare System
Shrestha, N. K., Nowacki, A. S., Burke, P. C., Terpeluk, P., Gordon, S. M.
10.1101/2021.06.02.21258231 — Posted: 2021-06-05 Discussion: Onsite
Health care use up to 6 months after COVID-19 in 700.000 children and adolescents: a pre-post study
Magnusson, K., Skyrud, K. D., Suren, P., Greve-Isdahl, M., Stordal, K., Kristoffersen, D. T., Telle, K. E.
10.1101/2021.06.02.21258211 — Posted: 2021-06-05
A Cluster-based Model of COVID-19 Transmission Dynamics
Shayak, B., Sharma, M. M.
10.1101/2021.06.02.21258243 — Posted: 2021-06-05
Efficacy of clarithromycin on COVID-19 pneumonia without oxygen administration; protocol for multicenter, open-label, randomized-controlled, 3-armed parallel group comparison, exploratory trial (CAME COVID study)
Yamamoto, K., Hosogaya, N., Sakamoto, N., Yoshida, H., Ishii, H., Yatera, K., Izumikawa, K., Yanagihara, K., Mukae, H.
10.1101/2021.06.02.21258257 — Posted: 2021-06-05

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).